@article{d99633664b6f4f579672d5402726cafd,
title = "Obesity and reproduction: a committee opinion",
abstract = "The purpose of this American Society for Reproductive Medicine Practice Committee report is to provide clinicians with principles and strategies for the evaluation and treatment of couples with infertility associated with obesity. This revised document replaces the Practice Committee document titled “Obesity and reproduction: an educational bulletin” last published in 2015 (Fertil Steril 2015;104:1116–26).",
keywords = "Infertility, overweight, ovulatory dysfunction, treatment",
author = "{Practice Committee of the American Society for Reproductive Medicine} and Alan Penzias and Ricardo Azziz and Kristin Bendikson and Tommaso Falcone and Karl Hansen and Micah Hill and Sangita Jindal and Suleena Kalra and Jennifer Mersereau and Richard Reindollar and Shannon, {Chevis N.} and Anne Steiner and Cigdem Tanrikut and Hugh Taylor and Belinda Yauger",
note = "Funding Information: This report was developed under the direction of the Practice Committees of the American Society for Reproductive Medicine (ASRM) as a service to its members and other practicing clinicians. Although this document reflects appropriate management of a problem encountered in the practice of reproductive medicine, it is not intended to be the only approved standard of practice or to dictate an exclusive course of treatment. Other plans of management may be appropriate, taking into account the needs of the individual patient, available resources, and institutional or clinical practice limitations. The Practice Committee and the Board of Directors of ASRM have approved this report. This document was reviewed by the ASRM members, and their input was considered in the preparation of the final document. The following members of the ASRM Practice Committee participated in the development of this document: Alan Penzias, M.D.; Ricardo Azziz, M.D. M.P.H. M.B.A.; Kristin Bendikson, M.D.; Tommaso Falcone, M.D.; Karl Hansen, M.D. Ph.D.; Micah Hill, D.O.; Sangita Jindal, Ph.D.; Suleena Kalra, M.D. M.S.C.E.; Jennifer Mersereau, M.D.; Richard Reindollar, M.D.; Chevis N. Shannon, Dr.P.H. M.P.H. M.B.A.; Anne Steiner, M.D. M.P.H.; Cigdem Tanrikut, M.D.; Hugh Taylor, M.D.; and Belinda Yauger, M.D. The Practice Committee acknowledges the special contribution of Karl Hansen, M.D. Ph.D.; Emily Jungheim, M.D.; Emily Evans-Hoeker, M.D.; Christina Boots, M.D.; Shayne Plosker, M.D.; Richard Legro, M.D.; and Juanita Henao, M.D. in the preparation of this document. All Committee members disclosed commercial and financial relationships with manufacturers or distributors of goods or services used to treat patients. The members of the Committee who were found to have conflicts of interest on the basis of the relationships disclosed did not participate in the discussion or development of this document. DIALOG: You can discuss this article with its authors and other readers athttps://www.fertstertdialog.com/posts/33631 Publisher Copyright: {\textcopyright} 2021 American Society for Reproductive Medicine",
year = "2021",
month = nov,
doi = "10.1016/j.fertnstert.2021.08.018",
language = "English (US)",
volume = "116",
pages = "1266--1285",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",
}
